{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:45:41Z","timestamp":1792521941849,"version":"4.5.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Microbiome consists of a large community of bacteria, yeast, protozoa, and viruses that co-exist in symbiosis with human hosts. Changes in microbiome, named \u201cdysbiosis,\u201d alter the interplay between microbiome and immune system triggering inflammation and contributing to the pathogenesis of connective tissue diseases (CTD). Interstitial lung diseases (ILD) are a group of pulmonary disorders characterized by lung tissue fibrosis and impaired lung function. The existence of a gut-lung axis is well demonstrated; however, it is not established whether gastrointestinal dysbiosis contributes to ILD development. ILD represent a major cause of morbidity and mortality in CTD patients. Lung microbiome changes and high microbial load are associated with worse prognosis and acute exacerbations in patients with CTD-ILD and especially in those affected by rheumatoid arthritis, systemic sclerosis and dermatomyositis. Probiotics are active microorganisms that normalize the intestinal flora and their use has been proposed as potential supportive treatment of CTD-ILD. Present knowledge of the relationships between dysbiosis and CTD-ILD development is largely incomplete and further studies are needed to validate this issue. Aim of this concise review is to report current knowledge on microbiome in CTD-ILD focusing on clinical lung aspects and therapeutic options.<\/jats:p>","DOI":"10.3389\/fmed.2026.1738689","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T14:37:02Z","timestamp":1774017422000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Microbiome in connective tissue diseases associated interstitial lung disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Francesco","family":"Puppo","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Genoa","place":["Genoa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto G.","family":"Carbone","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Genoa","place":["Genoa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.amjmed.2025.09.002","article-title":"Microbiomes in health, diseases and therapeutics.","volume":"139","author":"Goetzl","year":"2026","journal-title":"Am J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2611545","DOI":"10.1080\/19490976.2025.2611545","article-title":"The gut microbiota and host immunity synergistically orchestrate colonization resistance.","volume":"18","author":"Lia","year":"2026","journal-title":"Gut Microbes."},{"key":"B3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/genes17010116","article-title":"Composition and function of gut microbiome: from basic omics to precision medicine.","volume":"17","author":"Ma","year":"2026","journal-title":"Genes."},{"key":"B4","doi-asserted-by":"publisher","first-page":"946248","DOI":"10.3389\/fimmu.2022.946248","article-title":"Gut microbiota, leaky gut, and autoimmune diseases.","volume":"13","author":"Christovich","year":"2022","journal-title":"Front Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.3390\/biomedicines10123195","article-title":"The role of the microbiome in connective-tissue-associated interstitial lung disease and pulmonary vasculitis.","volume":"10","author":"Drakopanagiotakis","year":"2022","journal-title":"Biomedicines."},{"key":"B6","doi-asserted-by":"publisher","first-page":"6532","DOI":"10.3390\/ijms23126532","article-title":"Microbiome changes in connective tissue diseases and vasculitis: focus on metabolism and inflammation.","volume":"23","author":"La Barbera","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"104055","DOI":"10.1016\/j.ebiom.2022.104055","article-title":"Gut dysbiosis in rheumatic diseases: a systematic review and meta-analysis of 92 observational studies.","volume":"80","author":"Wang","year":"2022","journal-title":"EbioMedicine."},{"key":"B8","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/s41423-021-00661-4","article-title":"Gut microbiota-derived metabolites in the regulation of host immune responses and immune-related inflammatory diseases.","volume":"18","author":"Yang","year":"2021","journal-title":"Cell Mol Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3390\/ijms23020977","article-title":"Lung microbiome in idiopathic pulmonary fibrosis and other interstitial lung diseases.","volume":"23","author":"Amati","year":"2022","journal-title":"Int J Mol Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.rdc.2025.01.003","article-title":"Lung microbiome in autoimmune-associated interstitial lung disease.","volume":"51","author":"Wilson","year":"2025","journal-title":"Rheum Dis Clin N Am."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.3389\/fphys.2018.01168","article-title":"Paradigms of lung microbiota functions in health and disease, particularly, in asthma.","volume":"9","author":"Mathieu","year":"2018","journal-title":"Front Physiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1321315","DOI":"10.3389\/fcimb.2023.1321315","article-title":"Lung microbiome alterations in patients with anti-Jo1 antisynthetase syndrome and interstitial lung disease.","volume":"13","author":"Quintero-Puerta","year":"2023","journal-title":"Front Cell Infect Microbiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"595522","DOI":"10.3389\/fmed.2021.595522","article-title":"Role of the microbiome in interstitial lung diseases.","volume":"8","author":"Chioma","year":"2021","journal-title":"Front Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"240167","DOI":"10.1183\/20734735.0167-2024","article-title":"The lung microbiome in interstitial lung disease.","volume":"21","author":"Mikhail","year":"2025","journal-title":"Breathe."},{"key":"B15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3390\/biom14030247","article-title":"The role of lung microbiome in fibrotic interstitial lung disease\u2014A systematic review.","volume":"14","author":"Puiu","year":"2024","journal-title":"Biomolecules."},{"key":"B16","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/MCP.0000000000000399","article-title":"The microbiome in interstitial lung disease: from pathogenesis to treatment target.","volume":"23","author":"Salisbury","year":"2017","journal-title":"Curr Opin Pulm Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e70328","DOI":"10.1002\/hsr2.70328","article-title":"Metagenomic analysis of lung microbiome in patients with interstitial lung diseases and sarcoidosis: an experimental study.","volume":"8","author":"Takeuchi","year":"2025","journal-title":"Health Sci Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12931-025-03404-5","article-title":"Whole genome sequencing of the pulmonary microbiome in interstitial lung disease subtypes.","volume":"26","author":"Knudsen","year":"2025","journal-title":"Respir Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"114653","DOI":"10.1016\/j.intimp.2025.114653","article-title":"Idiopathic pulmonary fibrosis microenvironment: novel mechanisms and research directions.","volume":"155","author":"Gao","year":"2025","journal-title":"Int Immunopharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1055\/s-0044-1785673","article-title":"The oral-lung microbiome axis in connective tissue disease-related interstitial lung disease.","volume":"45","author":"Bongers","year":"2024","journal-title":"Semin Respir Crit Care Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1711299","DOI":"10.3389\/fmicb.2025.1711299","article-title":"Lung-gut axis, intestinal microbiota, and pulmonary fibrosis: mechanisms and therapeutic potential.","volume":"16","author":"Yang","year":"2025","journal-title":"Front Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1515\/rir-2023-0027","article-title":"Understanding the roles of the microbiome in autoimmune rheumatic diseases.","volume":"4","author":"Amarnani","year":"2023","journal-title":"Rheumatol Immunol Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1258246","DOI":"10.3389\/fcimb.2024.1258246","article-title":"The mechanism of gut-lung axis in pulmonary fibrosis.","volume":"14","author":"Dong","year":"2024","journal-title":"Front Cell Infect Microbiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"94379","DOI":"10.3389\/fmicb.2022.943791","article-title":"Gut microbiome and metabolites: the potential key roles in pulmonary fibrosis.","volume":"13","author":"Wu","year":"2022","journal-title":"Front Microbiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1007165","DOI":"10.3389\/fimmu.2022.1007165","article-title":"Gut microbiota and rheumatoid arthritis: from pathogenesis to novel therapeutic opportunities.","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40168-016-0206-x","article-title":"The lung microbiota in early rheumatoid arthritis and autoimmunity.","volume":"4","author":"Scher","year":"2016","journal-title":"Microbiome."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1331486","DOI":"10.3389\/fimmu.2024.1331486","article-title":"Rheumatoid arthritis and the intestinal microbiome: probiotics as a potential therapy.","volume":"15","author":"Yang","year":"2024","journal-title":"Front Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"16154","DOI":"10.3390\/ijms232416154","article-title":"The microbiome in systemic sclerosis: pathophysiology and therapeutic potential.","volume":"23","author":"Kim","year":"2022","journal-title":"Int J Mol Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/BOR.0000000000000899","article-title":"Gastrointestinal involvement in systemic sclerosis: pathogenesis, assessment, and treatment.","volume":"34","author":"Volkmann","year":"2022","journal-title":"Curr Opin Rheumatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1475528","DOI":"10.3389\/fimmu.2024.1475528","article-title":"Gut microbiome and metabolomics in systemic sclerosis: feature, link and mechanisms.","volume":"15","author":"Yao","year":"2024","journal-title":"Front Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.rdc.2025.01.002","article-title":"Advancing gastrointestinal microbiota research in systemic sclerosis.","volume":"51","author":"Bellocchi","year":"2025","journal-title":"Rheum Dis Clin N Am."},{"key":"B32","doi-asserted-by":"crossref","unstructured":"Andr\u00e9ason\n              K\n            \n            \n              Joshi\n              S\n            \n            \n              Labus\n              J\n            \n            \n              Young\n              A\n            \n            \n              Low\n              A\n            \n            \n              Smith\n              V\n            \n          \n          POS0557. Fecal Microbiota Signatures of Systemic Sclerosis-Associated Interstitial Lung Disease: An Exploration of the Gut-Lung Axis in an International Multicenter Study. Scientific Abstracts.\n          \n          2024","DOI":"10.1136\/annrheumdis-2024-eular.1168"},{"key":"B33","doi-asserted-by":"publisher","first-page":"918619","DOI":"10.3389\/fimmu.2022.918619","article-title":"A glimpse into the microbiome of Sjogren\u2019s syndrome.","volume":"13","author":"Deng","year":"2022","journal-title":"Front Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jdent.2018.08.010","article-title":"The role of natural salivary defences in maintaining a healthy oral microbiota.","volume":"80","author":"Lynge Pedersen","year":"2019","journal-title":"J Dent."},{"key":"B35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/imr.13360","article-title":"Intersection of the microbiome and immune metabolism in lupus.","volume":"325","author":"Garcia","year":"2024","journal-title":"Immunol Rev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1202850","DOI":"10.3389\/fimmu.2023.1202850","article-title":"Gut microbiota: a newly identified environmental factor in systemic lupus erythematosus.","volume":"14","author":"Yao","year":"2023","journal-title":"Front Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"686501","DOI":"10.3389\/fimmu.2021.686501","article-title":"Gut microbiome and metabolites in systemic lupus erythematosus: link, mechanisms and intervention.","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/acr2.11436","article-title":"Altered gut microbiome in patients with dermatomyositis.","volume":"4","author":"Bae","year":"2022","journal-title":"ACR Open Rheumatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/2211-5463.13334","article-title":"The composition of the lung microbiome differs between patients with dermatomyositis and rheumatoid arthritis associated with interstitial lung disease.","volume":"12","author":"Lou","year":"2022","journal-title":"FEBS Open Bio"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.3390\/microorganisms12112162","article-title":"Halophilic pectinase-producing bacteria from Arthrocnemum macrostachyum rhizosphere: potential for fruit-vegetable juice processing.","volume":"12","author":"Alswat","year":"2024","journal-title":"Microorganisms"},{"key":"B41","doi-asserted-by":"publisher","first-page":"12733","DOI":"10.3390\/cimb46110756","article-title":"Modification of intestinal flora can improve host metabolism and alleviate the damage caused by chronic hypoxia.","volume":"46","author":"Chen","year":"2024","journal-title":"Curr Issues Mol Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1478362","DOI":"10.3389\/fcimb.2024.1478362","article-title":"Periodontal bacteria influence systemic diseases through the gut microbiota.","volume":"14","author":"Xi","year":"2024","journal-title":"Front Cell Infect Microbiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"115123","DOI":"10.1016\/j.foodres.2024.115123","article-title":"Microbiota-derived succinic acid mediates attenuating effect of dietary tomato juice supplementation on steatohepatitis through enhancing intestinal barrier.","volume":"196","author":"Song","year":"2024","journal-title":"Food Res Int."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.3390\/nu16223970","article-title":"Probiotic therapy of gastrointestinal symptoms during COVID-19 infection: a randomized, double-blind, placebo-controlled, remote study.","volume":"16","author":"Horvath","year":"2024","journal-title":"Nutrients."},{"key":"B45","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s12602-023-10167-2","article-title":"Lactobacillus rhamnosus modulates lung inflammation and mitigates gut dysbiosis in a murine model of asthma-COPD overlap syndrome.","volume":"17","author":"Vasconcelos","year":"2025","journal-title":"Probiotics Antimicrob Proteins."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1196084","DOI":"10.3389\/fcimb.2023.1196084","article-title":"Lactobacillus acidophilus NCFM and Lactiplantibacillus plantarum Lp-115 inhibit Helicobacter pylori colonization and gastric inflammation in a murine model.","volume":"13","author":"Shen","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1032355","DOI":"10.3389\/fimmu.2023.1032355","article-title":"Potential targeted therapy based on deep insight into the relationship between the pulmonary microbiota and immune regulation in lung fibrosis.","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12916-024-03303-4","article-title":"Efficacy and safety of gut microbiota- based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trials.","volume":"22","author":"Zeng","year":"2024","journal-title":"BMC Medicine."},{"key":"B49","doi-asserted-by":"publisher","first-page":"110210","DOI":"10.1016\/j.jnutbio.2025.110210","article-title":"Dietary fiber-derived butyrate ameliorates pulmonary fibrosis by inhibiting YBX1 ubiquitination.","volume":"150","author":"Li","year":"2026","journal-title":"J Nutr Biochem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ard.2025.05.398","article-title":"POS0001 Investigating the therapeutic potential of intestinal microbiota in interstitial lung disease associated with connective tissue disease.","volume":"84","author":"Zhang","year":"2025","journal-title":"Ann. Rheumat. Dis."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1738689\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T14:37:04Z","timestamp":1774017424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1738689\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":50,"alternative-id":["10.3389\/fmed.2026.1738689"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1738689","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"article-number":"1738689"}}